Orchid Chemicals secures NOC from lenders to conclude deal with Hospira

07 Jun 2013 Evaluate

Orchid Chemicals and Pharmaceuticals has secured no objection certificates (NOCs) from the lenders to complete its $200 million deal with US-based Hospira Inc. The company now expects to close the deal within the end of this month. Orchid Chemicals plans to utilise these funds for repayment of debt around Rs 800 crore.

Back in August 2012, Orchid had entered into business transfer agreement (BTA)  with Hospira for the sale of former’s active pharmaceutical ingredient (API) manufacturing facility in Aurangabad, Maharashtra and an associated research and development (R&D) facility in Chennai for around $200 million.

The Business Transfer Agreement (BTA), which was expected to be sealed within March 31, 2013, was extended till June 30,2013 since the closing conditions were not met. The deal was also delayed as IDBI Bank approached the court with a dispute related to conversion of part of its money lended to the company to equity. Nevertheless, the bank sought the company to meet the conditions stated in its loan agreement before selling the business.

Orchid Pharma Share Price

819.00 -3.75 (-0.46%)
16-Dec-2025 10:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1785.10
Dr. Reddys Lab 1275.15
Cipla 1501.55
Zydus Lifesciences 921.55
Lupin 2084.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×